EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

Abroad (travel likely)RecruitingPHASE1

Conditions

EBV-Related Hodgkin Lymphoma · EBV-Related Lymphoproliferative Disorder · EBV Related Non-Hodgkin's Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston, Texas, United States
Contact: Study coordinator (Martha Mims, MD) · mmims@bcm.edu · 713-873-2010
Contact: Study coordinator (Anaid Reyes) · anaid.reyes@bcm.edu · 713-798-3832
Houston Methodist Hospital, Houston, Texas, United States
Contact: Study coordinator (Bilal Omer, MD) · bomer@bcm.edu · 832-824-6855
Texas Children's Hospital, Houston, Texas, United States
Contact: Study coordinator (Bilal Omer, MD) · bomer@bcm.edu · 832-824-6855
Baylor St. Luke's Medical Center, Houston, Texas, United States
Contact: Study coordinator (Akiva Diamond, MD) · Akiva.Diamond@bcm.edu
Contact: Study coordinator (Laura Marouf) · laura.marouf@bcm.edu · 713-798-2950

Study leads

Bilal Omer, MD
Principal Investigator
Baylor College of Medicine

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

Acute Leukemia · Acute Myeloid Leukemia · Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2

Minneapolis, United States